DaVita to Establish Operations in Brazil

USA - English

• Brazil - Português

SÃO PAULO, Sept. 30, 2015 /PRNewswire/ -- DaVita HealthCare Partners Inc. (NYSE: DVA), a leading global provider of kidney care services and a leading independent medical group in the United States, today announced plans to begin operations in Brazil. The company, which operates in 11 countries serving more than 1.5 million patients, aims to bring its global expertise and leading clinical outcomes to the country. 

DaVita plans to help Brazilian physicians grow their practice by providing them access to a worldwide network of experts, best-in-class training programs and the most advanced clinical and administrative service standards.

"Our objective in Brazil, as it is in all the countries in which DaVita HealthCare Partners operates, is to deliver world-class care and improve quality of life for our patients," said Dennis Kogod, CEO of DaVita's international operations. "In addition to bringing DaVita's leading kidney care services to the country, we look forward to partnering with the Brazilian government and payors in establishing and expanding integrated care functions."

"We have a proven clinical system focused on improving health care services, which allows physicians to achieve great results and spend more time with their patients," said Dr. Mahesh Krishnan, international chief medical officer and group vice president of research and development at DaVita. "DaVita invests heavily in clinical research and clinical innovation to improve the model of patient care, and, ultimately, patient outcomes."

There are more than 110,000 Brazilians on dialysis, a number that many studies suggest is on the rise due to the increasing prevalence of chronic kidney disease in the country.

DaVita and DaVita HealthCare Partners are trademarks or registered trademarks of DaVita HealthCare Partners Inc. All other trademarks are the property of their respective owners.

About DaVita Kidney Care
DaVita Kidney Care is a division of DaVita HealthCare Partners Inc., a Fortune 500® company that, through its operating divisions, provides a variety of health care services to patient populations globally. A leading provider of dialysis services headquartered in the United States, DaVita Kidney Care treats patients with chronic kidney failure and end stage renal disease. DaVita Kidney Care strives to improve patients' quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. As of June 30, 2015, DaVita Kidney Care operated or provided administrative services at 2,306 outpatient dialysis centers globally serving approximately 184,000 patients. DaVita Kidney Care supports numerous programs dedicated to creating positive, sustainable change in communities around the world. For more information, please visit DaVita.com.

Forward Looking Statements
This release may contain forward-looking statements within the meaning of the federal securities laws. All statements that do not concern historical facts are forward-looking statements and include, among other things, statements about our expectations, objectives, beliefs, intentions and/or strategies for the future, including the prospective growth, opportunities and performance of our business model in new and untested markets outside of the United States. Factors which could impact future results include the uncertainties associated with our ability to successfully launch  any market entry that we might be considering or announce, to ultimately operate profitably any international dialysis operations we invest in now or in the future that may initially generate losses and may ultimately never be profitable, and to overcome any significant change in local market conditions including the regulatory, political and economic environment and availability of skilled workers that may impact the economic viability of our international expansion initiatives, and the other risk factors set forth in DaVita's SEC filings, including its Annual Report on Form 10-K for the year ended December 31, 2014, and its subsequent quarterly reports filed on Form 10-Q. Any forward-looking statements should be considered in light of these risks and uncertainties. DaVita bases its forward-looking statements on information currently available to it at the time of this release, and it undertakes no obligation to update or revise any forward-looking statements, whether as a result of changes in underlying factors, new information, future events or otherwise.

Media Contact:
United States:
David Tauchen
+1 (303) 876-2802
[email protected]

Brazil:
Ariane Cordeiro
55 11 5503-2870
[email protected]

Ive Andrade
55 11 5503-2868
[email protected]

Logo - http://photos.prnewswire.com/prnh/20140318/DC85712LOGO

SOURCE DaVita HealthCare Partners Inc.